These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3518966)

  • 1. Norfloxacin versus pipemidic acid in complicated urinary tract infections due to susceptible pathogens: a comparative clinical trial.
    Del Favero A; Frongillo RF; Menichetti F; Boldrini F; Guerciolini R; Pauluzzi S
    Chemioterapia; 1986 Apr; 5(2):88-91. PubMed ID: 3518966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
    Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N
    Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quinolone-resistant Escherichia coli in the health area of a 650-bed hospital].
    Fernández Fernández A; Lantero Benedito M; Gastañares Hernando MJ; Undabeitia Santisteban E; Fernández Santos F; Castaño Rodríguez A; Gil Fabra J; Martínez Castellanos F; Otero Mauricio G
    Actas Urol Esp; 1994 Jun; 18(6):634-8. PubMed ID: 7942213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
    Cruciani M; Monzillo V; Navarra A; Tinelli C; Concia E
    Drugs Exp Clin Res; 1988; 14(8):533-7. PubMed ID: 3150350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of urinary infections: clinical perspectives.
    Fontana G; Laudi M; Carlone NA; Savoia D
    Chemioterapia; 1987 Feb; 6(1):45-9. PubMed ID: 3549009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pipemidinic acid as a urinary antiseptic--microbiological and clinical study].
    Minkov N; Zlatanov Z; Zozikov B; Khristova D
    Vutr Boles; 1985; 24(5):46-53. PubMed ID: 4090453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y; Nishino T
    Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trial of drugs for treating urological infections--pipemidic acid].
    Belovezhdov N; Talakova Ch; Angelova I; Chakŭrski I; Koĭchev A
    Vutr Boles; 1985; 24(2):61-5. PubMed ID: 3898589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pipemidic acid: a new antibiotic for the urinary tract. A comparative, double-blind study of pipemidic acid and amoxidillin].
    Oosterlinck W; Welvaert P; Verbaeys A; Schelfout W; Wijndaele JJ; de Maeyer P
    Acta Urol Belg; 1980 Oct; 48(4):471-7. PubMed ID: 7006346
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of urinary infections in gynecology. Comparative study of norfloxacin, oxolinic acid and pipemidic acid carried out on ambulatory patients].
    Capalbi A; Buzzi M; Alessandrini A; Allegra E; Mogini C; Di Salvo G
    Minerva Urol Nefrol; 1987; 39(4):383-9. PubMed ID: 3451376
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of lower urinary tract infections in children: single dose fosfomycin trometamol versus pipemidic acid.
    Careddu P; Borzani M; Scotti L; Varotto F; Garlaschi L; Fontana P
    Chemioterapia; 1987 Aug; 6(4):290-4. PubMed ID: 3652281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of norfloxacin in complicated and recurrent urinary tract infections.
    Schaeffer AJ
    Eur Urol; 1990; 17 Suppl 1():19-23. PubMed ID: 2191865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal.
    Das RN; Chandrashekhar TS; Joshi HS; Gurung M; Shrestha N; Shivananda PG
    Singapore Med J; 2006 Apr; 47(4):281-5. PubMed ID: 16572238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical contribution to the study of pipemidic acid in urinary tract infections in a urology clinic].
    Pagani G
    Clin Ter; 1980 Jul; 94(2):165-71. PubMed ID: 7004759
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quinolone resistance of Escherichia coli strains isolated from urinary tract infections].
    Agulla A; Montes I
    Enferm Infecc Microbiol Clin; 1994; 12(6):322. PubMed ID: 8080877
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative evaluation of norfloxacin and cinoxacin in the therapy of complicated infections of the urinary tract].
    Cristiano P; Morelli G; Simioli F; Iovene MR; Della Vittoria Scarpati M; Manguso L
    Minerva Med; 1989 Apr; 80(4):393-5. PubMed ID: 2657499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of norfloxacin in the treatment of urinary tract infections in Tikure Anbessa Hospital, Addis Ababa, Ethiopia.
    Mengesha B
    East Afr Med J; 1991 Nov; 68(11):844-52. PubMed ID: 1800077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections.
    Childs SJ
    Am J Med; 1993 Mar; 94(3A):105S-107S. PubMed ID: 8452164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial activity of norfloxacin and pipemidic acid in a randomized double-blind study].
    Zerqueni G; Rocca Rossetti S
    Minerva Urol Nefrol; 1984; 36(3):247-51. PubMed ID: 6241966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.